Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

50.350
+0.2500.50%
Volume:37.15M
Turnover:1.89B
Market Cap:207.24B
PE:37.05
High:51.900
Open:50.350
Low:50.150
Close:50.100
52wk High:54.450
52wk Low:28.480
Shares:4.12B
HK Float Shares:4.12B
Volume Ratio:1.25
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.359
ROE:11.38%
ROA:7.60%
PB:3.68
PE(LYR):37.05
PS:7.49

Loading ...

Movement Alert|WUXI BIO Rises 3.09% in Regular Trading, CXO Sector Rallies as Global Pharma Outsourcing Rate Breaks 50%

Market Focus
·
Sep 18

WUXI BIO: Zhisheng Chen Disposes, Long Position Falls to 1.47%

HK Disclosure
·
Sep 17

WuXi XDC Out-Licenses WuXiTecan-2 ADC Payload-Linker Platform to Ona Therapeutics

Reuters
·
Sep 17

Wuxi Biologics (Cayman) Stock Advances 1.5% in Hong Kong

Dow Jones
·
Sep 16

WuXi Biologics Makes Forbes China ESG 50 List for 2026

Reuters
·
Sep 16

Movement Alert|WUXI BIO Rises 3.21% in Regular Trading, CXO Sector Extends Mid-Year Earnings Rally

Market Focus
·
Sep 16

Wuxi Biologics (Cayman) Stock Advances 4.6% in Hong Kong

Dow Jones
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

Movement Alert|WUXI BIO Rises 3.06% in Regular Trading, CXO Sector Rallies on Valuation Recovery and Strong Fundamentals

Market Focus
·
Sep 14

Hong Kong Market Update | CRO Stocks Lead Gains as Interim Results Reinforce Sector Momentum, Multiple Firms Lift Guidance

Stock News
·
Sep 14

Goldman Sachs Sees Clear Recovery in China's CRO/CDMO Sector, Favorable on WuXi-Linked Stocks

Stock News
·
Sep 14

Wuxi Biologics (Cayman) Stock Slips 2.7% in Hong Kong

Dow Jones
·
Sep 10

Movement Alert|WUXI BIO Falls 3.07% in Regular Trading, Trading at 47.44 HKD

Market Focus
·
Sep 10

WuXi Biologics Issues 1.20 Million New Shares; 39.82 Million Shares Await Cancellation

Bulletin Express
·
Sep 09

WuXi Biologics Files HKEX Next-Day Disclosure, Share Capital Rises by 1.2 Million Shares

Reuters
·
Sep 09

Transcenta Licenses HiCB Bioprocessing Technology to WuXi Biologics for RMB 10 Million Upfront

Reuters
·
Sep 09

Transcenta Holding - to Receive RMB 10 Mln Upfront Payment and Milestone Payments

THOMSON REUTERS
·
Sep 09

Transcenta Holding - Grants WuXi Biologics Non-Exclusive License to Hicb Platform and Excelpro Cell Culture Media

THOMSON REUTERS
·
Sep 09

Wuxi Biologics (Cayman) Stock Climbs 1.7% in Hong Kong

Dow Jones
·
Sep 08

WuXi Biologics Files HKEX Next-Day Disclosure Return, Issues 1,804,090 New Shares

Reuters
·
Sep 07